Tyra Biosciences (TYRA) EBIT (2020 - 2026)
Tyra Biosciences (TYRA) reported EBIT of -$42.0 million for Q1 2026, down 31.86% on a YoY basis from -$61.6 million in Q1 2025, and down 15.01% quarter-over-quarter from -$36.5 million in Q4 2025.
Tyra Biosciences (TYRA) EBIT (2020 - 2026) Analysis & Trends
Tyra Biosciences has reported EBIT for 7 years, with the latest figure at -$42.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 31.86% year-over-year to -$42.0 million; the trailing twelve-month figure through Mar 2026 stood at -$142.9 million (down 25.66% YoY), and the FY2025 full-year result was -$132.8 million, down 27.44% from the prior year.
- EBIT for Q1 2026 stood at -$42.0 million, down from -$36.5 million in the prior quarter.
- The five-year high for EBIT was -$13.6 million in Q3 2022, with the low at -$42.0 million in Q1 2026.
- Historically, EBIT has averaged -$24.6 million across 5 years, with a median of -$24.0 million in 2023.
- Annual changes were most pronounced in 2022 — EBIT plunged 252.27% — and 2023, when it increased 3.37%.
- Tyra Biosciences' EBIT stood at -$15.0 million in 2022, then plunged by 70.69% to -$25.6 million in 2023, then decreased by 16.03% to -$29.7 million in 2024, then declined by 22.77% to -$36.5 million in 2025, then slipped by 15.01% to -$42.0 million in 2026.
- The last three EBIT figures came in at -$42.0 million (Q1 2026), -$36.5 million (Q4 2025), and -$32.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | -42.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.00 Mn |
| Dec 31, 2025 | -36.52 Mn |
| Sep 30, 2025 | -32.94 Mn |
| Jun 30, 2025 | -31.45 Mn |
| Mar 31, 2025 | -31.85 Mn |
| Dec 31, 2024 | -29.74 Mn |
| Sep 30, 2024 | -28.60 Mn |
| Jun 30, 2024 | -23.53 Mn |
| Mar 31, 2024 | -22.32 Mn |
| Dec 31, 2023 | -25.63 Mn |
| Sep 30, 2023 | -23.96 Mn |
| Jun 30, 2023 | -16.01 Mn |
| Mar 31, 2023 | -14.33 Mn |
| Dec 31, 2022 | -15.02 Mn |
| Sep 30, 2022 | -13.65 Mn |
| Jun 30, 2022 | -15.43 Mn |
| Mar 31, 2022 | -14.83 Mn |
| Dec 31, 2021 | -9.93 Mn |
| Sep 30, 2021 | -6.64 Mn |
| Jun 30, 2021 | -5.51 Mn |